Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tw HER2 Positive Breast Cancer Productivity & Utility Study

NCT04011085 is registered in ClinicalTrials.gov with Taiwan Epidemiology Association as lead sponsor.

NCT NCT04011085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04011085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tw HER2 Positive Breast Cancer Productivity & Utility Study
Lead sponsor
Taiwan Epidemiology Association
Phase
Observational
Overall status
Unknown status
Start date
December 24, 2018
Completion date
December 31, 2019
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast cancer